18962-07-7

Basic information

• Product Name: 4-ISOBUTOXY-BENZALDEHYDE
• Synonyms: AKOS B000265;4-ISOBUTOXY-BENZALDEHYDE;Benzaldehyde, 4-(2-methylpropoxy)-;FeBuxostat Impurity 34
• CAS NO: 18962-07-7
• Molecular Formula: C₁₁H₁₄O₂
• Molecular Weight: 178.23
• Mol File: 18962-07-7.mol
• Article Data: 19

Chemical Properties

• Melting Point: 155℃
• Boiling Point: 74°C/0.08mm
• Flash Point: 118.9±13.4℃
• Appearance: Light yellow powder
• Density: 1.018±0.06 g/cm3 (20 ºC 760 Torr)
• Vapor Pressure: 0.0037mmHg at 25°C
• Refractive Index: 1.5344 (589.3 nm 20℃)
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• Solubility: DMSO (Slightly), Methanol (Slightly)
• CAS DataBase Reference: 4-ISOBUTOXY-BENZALDEHYDE(CAS DataBase Reference)
• NIST Chemistry Reference: 4-ISOBUTOXY-BENZALDEHYDE(18962-07-7)
• EPA Substance Registry System: 4-ISOBUTOXY-BENZALDEHYDE(18962-07-7)

Safety Data

• Hazard Codes: Xi
• HazardClass: IRRITANT
• Hazardous Substances Data: 18962-07-7(Hazardous Substances Data)

Usage

Uses

4-Isobutoxybenzaldehyde to treat neurodegenerative diseases.

InChI:InChI=1/C11H14O2/c1-9(2)8-13-11-5-3-10(7-12)4-6-11/h3-7,9H,8H2,1-2H3

Upstream product

• 78-77-3 Isobutyl bromide 
• 123-08-0 4-hydroxy-benzaldehyde 
• 513-38-2 Isobutyl iodide 
• 497-19-8 sodium carbonate 
• 513-36-0 isobutyryl chloride 
• 1126-75-6 (isobutyloxy)benzene 
• 78-83-1 2-methyl-propan-1-ol 
• 459-57-4 4-fluorobenzaldehyde 
• 100-97-0 hexamethylenetetramine 
• 40141-14-8 4-isobutoxybenzyl chloride 

Downstream Products

• 90672-89-2 (4-Isobutoxy-phenyl)-isothiazol-5-yl-methanol 
• 119103-97-8 4-isobutoxy-trans-cinnamic acid 
• 865137-99-1 3-(chloromethyl)-4-isobutoxybenzaldehyde 
• 4734-09-2 1-[4-(2-methylpropyloxy)phenyl]methanamine 
• 955997-87-2 N,N'-bis(4-isobutoxybenzyl)urea 
• 706779-91-1 N-(1-methylpiperidin-4-yl)-N-(4-fluorophenylmethyl)-N′-(4-(2-methylpropyloxyl)phenylmethyl)carbamide 
• 865138-01-8 (4-isobutoxy-3-{[(2-phenylethyl)(4-phenyl-1,3-thiazol-2-yl)amino]methyl}phenyl)methanol 
• 865138-00-7 4-isobutoxy-3-{[(2-phenylethyl)(4-phenyl-1,3-thiazol-2-yl)amino]methyl}benzaldehyde 
• 706782-28-7 Pimavanserin tartrate 

Relevant articles and documents

An improved process for the preparation of pimavanserin tartrate

A practical synthetic route to pimavanserin tartrate, in which the target compound was obtained with 99.84% purity and in 46% total yield via a 5-step synthesis starting from 4-hydroxybenzaldehyde and (4-fluorophenyl)methanamine, is reported. The main advantages of the route include inexpensive starting materials, mild reaction conditions and an acceptable overall yield.

Application of pimavanserin in preparation of antitumor drugs

The invention relates to application of pimavanserin in preparation of antitumor drugs, belongs to the technical field of medicines, and particularly relates to novel application of pimavanserin in preparation of antitumor drugs. The structural formula of the pimavanserin is shown in the formula I. The biological activity test of the compound shows that the compound has antitumor activity and is a novel antitumor drug.

PROCESSES AND INTERMEDIATES FOR THE PREPARATION OF PIMAVANSERIN

The present disclosure relates to novel, safe and efficient processes for the synthesis of Pimavanserin and salts thereof, as well as novel intermediates that can be used in these processes.